Stuart Burri News Today

/PRNewswire/ -- Fuse Oncology, an oncology software solutions company, announces that it has officially closed an oversubscribed Series A. Among the largest...

Combining radiotherapy-based, metastasis-directed therapy with hormone therapy led to better progression-free survival for patients with oligometastatic prostate cancer.

Prophylactic radiotherapy for asymptomatic bone metastases could become standard of care after a randomized trial showed that it improved overall survival as well as reducing skeletal-related events.

CHARLOTTE – Atrium Health is breaking ground on a state-of-the-art facility that will bring two advanced radiation therapies to children and adult patients with complex tumors.

Business Scoop provides news and views on Business and Markets from New Zealand